The cost of the Breyna inhaler without insurance can vary significantly. Patients have reported paying between $150 and $300 per inhaler, depending on the pharmacy and location. Some sources indicate a list price of approximately $170 per inhaler for Breyna [1].
What is Breyna?
Breyna is a biosimilar to albuterol sulfate, a widely used bronchodilator prescribed to treat or prevent wheezing and shortness of breath in people with lung problems such as asthma and chronic obstructive pulmonary disease (COPD) [1]. It is an inhaled medication used to quickly relieve symptoms of bronchospasm.
How does Breyna work?
Breyna contains albuterol, a beta-2 adrenergic agonist. When inhaled, albuterol relaxes the muscles in the airways, opening them up and making it easier to breathe. It is typically used on an as-needed basis to treat acute breathing difficulties [1].
When did Breyna become available?
Breyna was approved by the U.S. Food and Drug Administration (FDA) in June 2021 and became available for prescription use thereafter. It is manufactured by Momenta Pharmaceuticals and Pfizer [1].
Are there other albuterol inhalers available?
Yes, albuterol sulfate is available in multiple forms, including generic and branded inhalers. Ventolin HFA and ProAir HFA are examples of other albuterol inhalers. Breyna is a biosimilar, meaning it is highly similar to an existing albuterol inhaler (the reference product) with no clinically meaningful differences in terms of safety, purity, and potency. This means it offers a similar therapeutic effect [1].
How can I find lower prices for Breyna?
Patients seeking to lower the cost of Breyna may explore several options. Some may be eligible for patient assistance programs offered by the manufacturer, though these often have income restrictions. Checking prices at different pharmacies can also reveal cost variations. Discount cards or coupons for prescription medications may also be available, though their applicability to biosimilars can vary [1].
What is the difference between a biosimilar and a generic?
While both biosimilars and generics offer less expensive alternatives to originator drugs, they apply to different types of medications. Generics are exact copies of small-molecule drugs, while biosimilars are highly similar to large-molecule biologic drugs. Breyna, being a biosimilar, is an alternative to an already approved albuterol inhaler [1].
Sources
1. DrugPatentWatch.com